Publikationen - Institut für Radiopharmazeutische Krebsforschung
8 Publikationen2024
Chelator Impact: Investigating the Pharmacokinetic Behavior of Copper-64 Labeled PD-L1 Radioligands
Krutzek, F.; Donat, C.; Stadlbauer, S.
-
EJNMMI Radiopharmacy and Chemistry 9(2024), 14
DOI: 10.1186/s41181-024-00243-5
2023
Preparation of 18F-Labeled Tracers Targeting Fibroblast Activation Protein via Sulfur [18F]Fluoride Exchange Reaction
Craig, A.; Kogler, J.; Laube, M.; Ullrich, M.; Donat, C.; et al. (8 authors)
-
Pharmaceutics 15(2023)12, 2749
DOI: 10.3390/pharmaceutics15122749
Exploring Hydrophilic PD-L1 Radiotracers Utilizing Phosphonic Acids: Insights Into Unforeseen Pharmacokinetics
Krutzek, F.; Donat, C.; Stadlbauer, S.
-
International Journal of Molecular Sciences 24(2023)20, 15088
DOI: 10.3390/ijms242015088
Design, Synthesis, and Biological Evaluation of Small Molecule Based Radioligands with Improved Pharmacokinetic Properties for Imaging of Programmed Death Ligand 1
Krutzek, F.; Donat, C.; Ullrich, M.; Stadlbauer, S.
-
Journal of Medicinal Chemistry 66(2023)23, 15894-15915
DOI: 10.1021/acs.jmedchem.3c01355
Design and Biological Evaluation of Small-Molecule PET-Tracers for Imaging of Programmed Death Ligand 1
Krutzek, F.; Donat, C.; Ullrich, M.; Zarschler, K.; Ludik, M.-C.; et al. (9 authors)
-
Cancers 15(2023), 2638
DOI: 10.3390/cancers15092638
2022
Development of Radiotracers for Imaging of the PD-1/PD-L1 Axis
Krutzek, F.; Kopka, K.; Stadlbauer, S.
-
Pharmaceuticals 15(2022), 747
DOI: 10.3390/ph15060747
2021
Radiolabeled Silicon-Rhodamines as Bimodal PET/SPECT-NIR Imaging Agents
Kanagasundaram, T.; Laube, M.; Wodtke, J.; Kramer, S. C.; Stadlbauer, S.; et al. (7 authors)
-
Pharmaceuticals 14(2021)11, 1155
DOI: 10.3390/ph14111155
The PSMA-11-derived hybrid molecule PSMA-914 specifically identifies prostate cancer by preoperative PET/CT and intraoperative fluorescence imaging
Eder, A.; Omrane, M.; Stadlbauer, S.; Roscher, M.; Khoder, W.; et al. (11 authors)
-
European Journal of Nuclear Medicine and Molecular Imaging 48(2021)6, 2057-2058
DOI: 10.1007/s00259-020-05184-0
